ArticleChinese medicine2022

Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro.

Qinhai Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.